CAMBRIDGE, Mass., March 28, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare diseases, announced today that the company will participate in the 11th Annual Needham Healthcare Conference in New York. Marc D. Beer, CEO of Aegerion, is scheduled to present on Tuesday, April 3, 2012 at 10:40 a.m. ET.
